Literature DB >> 31262683

Serum 25-Hydroxyvitamin D Levels and Depression in Older Adults: A Dose-Response Meta-Analysis of Prospective Cohort Studies.

Haibin Li1, Dianqin Sun2, Anxin Wang1, Huiying Pan2, Wei Feng1, Chee H Ng3, Gabor S Ungvari4, Lixin Tao1, Xia Li5, Wei Wang6, Yu-Tao Xiang7, Xiuhua Guo8.   

Abstract

OBJECTIVE: The association between serum vitamin D and risk of depression in older adults is controversial. We performed a dose-response meta-analysis of prospective cohort studies to examine the association between serum 25-hydroxyvitamin D [25(OH)D] concentrations and the risk of depression in older population.
METHODS: Studies published before February 2018 in the PubMed, Cochrane Library, Web of Science, PsycINFO, and EMBASE databases were systematically searched. Prospective cohort studies that examined the association between serum 25(OH)D levels and the risk of depression in older adults were included. A random-effects model was used to calculate the pooled hazard ratio and the corresponding 95% confidence intervals. A nonlinear dose-response association was examined using restricted cubic spline functions.
RESULTS: Six prospective studies covering 16,287 older adults with 1,157 cases of depression were included and analyzed. The pooled hazard ratio of depression for per 10-ng/mL increment in serum 25(OH)D was 0.88 (95% confidence intervals: 0.78-0.99, I2 = 79.0%, p <0.001 for heterogeneity). A linear dose-response association between serum 25(OH)D concentrations and incident depression was observed (p = 0.96 for nonlinearity).
CONCLUSION: Serum 25(OH)D concentration is negatively associated with the risk of depression in older adults. This meta-analysis suggests that increasing 25(OH)D levels may be a useful approach to reduce the risk of depression in older adults and highlights the need for further large-scale clinical studies.
Copyright © 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Serum 25-hydroxyvitamin D; depression; dose–response; meta-analysis

Year:  2019        PMID: 31262683     DOI: 10.1016/j.jagp.2019.05.022

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  13 in total

Review 1.  Role of Neural Stem Cells and Vitamin D Receptor (VDR)-Mediated Cellular Signaling in the Mitigation of Neurological Diseases.

Authors:  Chinnappa A Uthaiah; Narasimha M Beeraka; R Rajalakshmi; C M Ramya; SubbaRao V Madhunapantula
Journal:  Mol Neurobiol       Date:  2022-04-27       Impact factor: 5.590

2.  Cholecalciferol Supplementation Does Not Affect the Risk of HIV Progression, Viral Suppression, Comorbidities, Weight Loss, and Depression among Tanzanian Adults Initiating Antiretroviral Therapy: Secondary Outcomes of a Randomized Trial.

Authors:  Alfa Muhihi; Wafaie W Fawzi; Said Aboud; Tumaini J Nagu; Nzovu Ulenga; Molin Wang; Ferdinand Mugusi; Christopher R Sudfeld
Journal:  J Nutr       Date:  2022-08-09       Impact factor: 4.687

3.  Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.

Authors:  Olivia I Okereke; Charles F Reynolds; David Mischoulon; Grace Chang; Chirag M Vyas; Nancy R Cook; Alison Weinberg; Vadim Bubes; Trisha Copeland; Georgina Friedenberg; I-Min Lee; Julie E Buring; JoAnn E Manson
Journal:  JAMA       Date:  2020-08-04       Impact factor: 56.272

4.  Vitamin D, Depressive Symptoms, and Covid-19 Pandemic.

Authors:  Gilciane Ceolin; Giulia Pipolo Rodrigues Mano; Natália Schmitt Hames; Luciana da Conceição Antunes; Elisa Brietzke; Débora Kurrle Rieger; Júlia Dubois Moreira
Journal:  Front Neurosci       Date:  2021-05-13       Impact factor: 4.677

5.  A prospective study into change of vitamin D levels, depression and frailty among depressed older persons.

Authors:  Karen S van den Berg; Johanna M Hegeman; Rob H S van den Brink; Didi Rhebergen; Richard C Oude Voshaar; Radboud M Marijnissen
Journal:  Int J Geriatr Psychiatry       Date:  2021-02-25       Impact factor: 3.485

6.  Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil.

Authors:  Gilciane Ceolin; Luísa Harumi Matsuo; Susana Cararo Confortin; Eleonora D'Orsi; Débora Kurrle Rieger; Júlia Dubois Moreira
Journal:  Nutr J       Date:  2020-11-14       Impact factor: 3.271

7.  Plasma phospholipid n-3 polyunsaturated fatty acids and major depressive disorder in Japanese elderly: the Japan Public Health Center-based Prospective Study.

Authors:  Kei Hamazaki; Yutaka J Matsuoka; Taiki Yamaji; Norie Sawada; Masaru Mimura; Shoko Nozaki; Ryo Shikimoto; Shoichiro Tsugane
Journal:  Sci Rep       Date:  2021-02-17       Impact factor: 4.379

Review 8.  Vitamin D in the time of the coronavirus (COVID-19) pandemic - a clinical review from a public health and public mental health perspective.

Authors:  Ursula Werneke; Fiona Gaughran; David M Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2021-07-09

Review 9.  Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases-An Umbrella Review.

Authors:  Friederike Maretzke; Angela Bechthold; Sarah Egert; Jana B Ernst; Debora Melo van Lent; Stefan Pilz; Jörg Reichrath; Gabriele I Stangl; Peter Stehle; Dorothee Volkert; Michael Wagner; Julia Waizenegger; Armin Zittermann; Jakob Linseisen
Journal:  Nutrients       Date:  2020-03-31       Impact factor: 5.717

10.  Causal inference and evidence-based recommendations in occupational health and safety research.

Authors:  Reiner Rugulies; Alex Burdorf
Journal:  Scand J Work Environ Health       Date:  2020-10-02       Impact factor: 5.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.